Neurological Rare Disease Biologics Market

Neurological Rare Disease Biologics Market is segmented by Product (Biologic Therapeutics, Gene Therapy Products, Oligonucleotide Therapies, Cell-Based Biologics, Enzyme Replacement Therapies), Application (Neurodegenerative Disorders, Neuromuscular Disorders, Neurogenetic Rare Diseases, Autoimmune Neurological Disorders), End Use (Pharmaceutical & Biotechnology Companies, Specialty Clinics & Hospitals, Academic & Research Institutes, Contract Research Organizations (CROs)), and Region, with forecasts covering the period from 2026 to 2036.